Impaired Satiety Effect of GLP-1 Agonist in Obesity Is Associated With GLP-1 Resistance in Intestinal Afferent Nerves

被引：0
|
作者：
Al-Helaili, Alaa
Wang, Beini
Beyak, Michael
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1784
引用
收藏
页码：S842 / S842
页数：1
相关论文
共 50 条
  • [1] Obesity and GLP-1
    De Oca, Alejandra Perez-Montes
    Pellitero, Silvia
    Puig-Domingo, Manel
    MINERVA ENDOCRINOLOGY, 2021, 46 (02): : 168 - 176
  • [2] The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
    Crane, James
    McGowan, Barbara
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (02) : 92 - 107
  • [3] Leptin resistance mice is associated with impaired GLP-1 secretion
    Anini, Y
    Brubaker, PL
    DIABETES, 2002, 51 : A338 - A338
  • [4] Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Torekov, S. S.
    Madsbad, S.
    Holst, J. J.
    OBESITY REVIEWS, 2011, 12 (08) : 593 - 601
  • [5] GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
    Pourkarim, Fariba
    Entezari-Maleki, Taher
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2303 - 2304
  • [6] New GLP-1 Agonist in Patients with Obesity Disorders
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (21) : 1339 - 1339
  • [7] GLP-1 Agonists for Obesity
    Langland, James T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (08):
  • [8] GLP-1 Agonists for Obesity
    Kurian, Marina
    Rogers, Ann M.
    Peterson, Richard M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (08):
  • [9] GLP-1 Agonists for Obesity
    Dellgren, Johan
    Emanuel, Ezekiel J.
    Persad, Govind
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (08):
  • [10] Obesity and GLP-1 RAs
    Bright, Tamis
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 1 - 2
12345